Literature DB >> 12056715

Acute transient encephalopathy after paclitaxel infusion: report of three cases.

C G Ziske1, B Schöttker, M Gorschlüter, U Mey, R Kleinschmidt, U Schlegel, T Sauerbruch, I G H Schmidt-Wolf.   

Abstract

Paclitaxel (Taxol) is a diterpene plant product and antineoplastic agent that promotes the assembly of microtubules as well as stabilizing their formation by preventing depolymerization. Myelosuppression was found to be dose-limiting, but peripheral neurotoxicity is also a well known side-effect. Central nervous system toxicity is rare, probably because paclitaxel does not cross the blood-brain barrier. We observed three patients who presented with acute encephalopathy within 6 h after infusion of paclitaxel at normal doses. All patients had received prior whole brain irradiation (WBI) and one patient had prior brain metastasectomy. Computer tomography and magnetic resonance imaging showed no evidence of cerebral metastases. An effect from other organ toxicities was excluded in all patients. All recovered spontaneously within 4-6 h. From this we can conclude that paclitaxel can cause severe acute transient encephalopathy, which may occur more frequently after prior WBI and/or surgery due to alteration of small vessel function.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12056715     DOI: 10.1093/annonc/mdf025

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  12 in total

Review 1.  Taxane-induced neurotoxicity: Pathophysiology and therapeutic perspectives.

Authors:  Robson da Costa; Giselle F Passos; Nara L M Quintão; Elizabeth S Fernandes; João Raphael L C B Maia; Maria Martha Campos; João B Calixto
Journal:  Br J Pharmacol       Date:  2020-06-03       Impact factor: 8.739

2.  Electrophysiological evaluation of visual pathways in paclitaxel-treated patients.

Authors:  V Scaioli; A Caraceni; C Martini; S Curzi; G Capri; G Luca
Journal:  J Neurooncol       Date:  2005-08-25       Impact factor: 4.130

Review 3.  [White matter alterations after chemotherapy and radiation].

Authors:  A Simgen
Journal:  Radiologe       Date:  2018-12       Impact factor: 0.635

4.  Acute transient encephalopathy after weekly paclitaxel infusion.

Authors:  Sadık Muallaoğlu; Murat Koçer; Nilüfer Güler
Journal:  Med Oncol       Date:  2011-05-27       Impact factor: 3.064

Review 5.  Epilepsy in brain metastasis: an emerging entity.

Authors:  Roberta Rudà; Francesca Mo; Alessia Pellerino
Journal:  Curr Treat Options Neurol       Date:  2020-02-08       Impact factor: 3.598

6.  The chemotherapeutic agent paclitaxel selectively impairs learning while sparing source memory and spatial memory.

Authors:  Alexandra E Smith; Richard A Slivicki; Andrea G Hohmann; Jonathon D Crystal
Journal:  Behav Brain Res       Date:  2016-11-28       Impact factor: 3.332

Review 7.  Neurological adverse effects caused by cytotoxic and targeted therapies.

Authors:  David Schiff; Patrick Y Wen; Martin J van den Bent
Journal:  Nat Rev Clin Oncol       Date:  2009-08-25       Impact factor: 66.675

8.  Efficient expression of single chain variable fragment antibody against paclitaxel using the Bombyx mori nucleopolyhedrovirus bacmid DNA system and its characterizations.

Authors:  Gorawit Yusakul; Seiichi Sakamoto; Hiroyuki Tanaka; Satoshi Morimoto
Journal:  J Nat Med       Date:  2016-03-03       Impact factor: 2.343

9.  Paclitaxel- and/or cisplatin-induced ocular neurotoxicity: a case report and literature review.

Authors:  Ying Li; Yanping Li; Junyu Li; Guoliang Pi; Wenyong Tan
Journal:  Onco Targets Ther       Date:  2014-07-31       Impact factor: 4.147

10.  Seizure following chemotherapy (paclitaxel and cisplatin) in a patient of carcinoma cervix.

Authors:  Rohitashwa Dana; R K Spartacus; Shweta Mutha; Prashanth Bhat
Journal:  Indian J Pharmacol       Date:  2016 Nov-Dec       Impact factor: 1.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.